ADMA BIOLOGICS, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADMA Biologics, Inc., a Delaware corporation, on September 5, 2018. The report discloses an upcoming investor presentation scheduled for the same date at the 20th Annual Rodman & Renshaw Global Investment Conference in New York, New York.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to announce an event and file accompanying presentation materials.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to distribute the Investor Presentation to the public.
Guidance, Outlook, and Risks
The filing references an attached Investor Presentation (Exhibit 99.1) which contains forward-looking statements. The text directs readers to Exhibit 99.1 for a discussion of risks and uncertainties related to these statements. The presentation was webcast live and is available on the company's website.
Key Facts for Investor Verification
- Verify the content of the September 2018 Investor Presentation filed as Exhibit 99.1 for specific financial guidance and operational updates.
- Confirm the company's status as an emerging growth company as indicated in the filing.
- Review the risk factors detailed in the attached presentation slides regarding forward-looking statements.